Navigation and service

focus

  1. About us
  2. Medicinal Products
  3. Federal Opium Agency
  4. Medical Devices
  5. Research
Federal Institute for Drugs and Medical Devices

About us

The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) is an independent federal higher authority within the portfolio of the Federal Ministry of Health. More

Medical Products

Medicinal Products

Medicinal products are substances that are used to treat diseases, to relieve complaints, or to prevent such diseases or complaints in the first place. More

Federal Opium Agency

Federal Opium Agency

The Bundesopiumstelle (Federal Opium Agency) is one of 13 departments at the Federal Institute for Drugs and Medical Devices. More

Medical Devices

Medical Devices

Medical devices are products that have a medical purpose and are intended by the manufacturer for use in humans. More

Research

Research

Research at the BfArM concentrates on important and contemporary research focal points with regard to the marketing authorisation of medicinal products and improving the safety thereof as well as concerning the recording and assessment of risks in connection with medical devices. More

About us

(The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) is an independent federal higher authority within the portfolio of the Federal Ministry of Health. More

  1. Risk information on
    medicinal products
  2. Risk information on
    medical devices

Risk information on
medicinal products

2015.07.23Dear Doctor Letter (Rote-Hand-Brief) on the use of intrauterine devices (IUDs): …

In view of updated results of the "European Active Surveillance Study for Intrauterine Devices” (EURAS-IUD), the company Jenapharm GmbH & Co. KG is circulating information on the …

2015.07.15Petnidan® Syrup, 50 mg/ml oral solution: Possibility of counterfeits of the …

The BfArM has received information that counterfeit packs of the medicinal product Petnidan® Syrup, 50 mg/ml oral solution (Marketing Authorisation Holder: Desitin Arzneimittel GmbH) are on …

more

2015.07.10Information Letter on Dacogen 50 mg, powder for concentrate for solution for …

The company Janssen-Cilag GmbH is circulating information on measures to improve stability for reconstitution and shelf life of Dacogen.

2015.07.10Information Letter on SGLT2 inhibitors: Risk of diabetic ketoacidosis

The companies AstraZeneca AB, Boehringer Ingelheim International GmbH and Janssen-Cilag International N.V. are circulating information on the risk of diabetic ketoacidosis under treatment with …

Overview

Risk information on
medical devices

2015.01.29Advices for the application of NaCl basin liners

Advices for the application of NaCl basin liners

more

2014.11.18Recommendations on the approach to patients with Riata and Riata ST leads (St.

The German Cardiac Society (DGK) has published recommendations regarding patients with silicone insulated defibrillation leads Riata and Riata ST of St. Jude Medical.

more

2014.03.20Recommendation in relation to the recall of the intragastric balloon Heliosphere …

Recall of the intragastric balloon Heliosphere Newtech -Newtech 720.

more

2013.08.27Weld control of the hoist Omnilift G2

Weld control of the hoist Omnilift G2 of the former manufacturer Weiner Innovative Medizintechnik

more

Overview

Additional Information

Reporting risks to the BfArM

Advice Procedures